INSPECT program

The Indiana Legislature approved file SB262 ("INSPECT program"), by a recorded vote of 141 to 0. Last action: March 5, 2026.

Indiana file SB262, before the Indiana Legislature. Passed as of 2026-03-05.

Official summary

Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.

How they voted

Yes (141)

Did not vote / other (9)

Read the official record for SB262

See everything up for a vote · This week in Indiana · See what we have filed with the clerk